Le cluster Thyroid Neoplasms (radionuclide imaging) - Carcinoma (radionuclide imaging)
| 000160 (1999) | F Kraeber-Bodéré (France) ; A Faivre-Chauvet ; C Saï-Maurel ; L Campion ; M Fiche ; E Gautherot ; J Le Boterff ; J Barbet ; J F Chatal ; P Thédrez | Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: comparison of iodine 131-labeled F(ab')2 and pretargeted bivalent hapten and evaluation of repeated injections. |
| 000166 (1999) | E Gautherot (France) ; F Kraeber-Bodéré ; L Daniel ; M Fiche ; E Rouvier ; C Saï-Maurel ; P Thedrez ; J F Chatal ; J Barbet | Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody. |
| 000213 (1995) | F Tenenbaum (France) ; J Lumbroso ; M Schlumberger ; B Caillou ; P Fragu ; C Parmentier | Radiolabeled somatostatin analog scintigraphy in differentiated thyroid carcinoma. |
| 000023 (2012) | Pierre-Yves Salaun (France) ; Loïc Campion ; Claire Bournaud ; Alain Faivre-Chauvet ; Jean-Philippe Vuillez ; David Taieb ; Catherine Ansquer ; Caroline Rousseau ; Françoise Borson-Chazot ; Stéphane Bardet ; Aurore Oudoux ; Bertrand Cariou ; Eric Mirallié ; Chien-Hsing Chang ; Robert M Sharkey ; David M Goldenberg ; Jean-François Chatal ; Jacques Barbet ; Françoise Kraeber-Bodéré | Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement. |
| 000125 (2004) | Francesco Giammarile (France) ; Claire Houzard ; Claire Bournaud ; Zakia Hafdi ; Genevieve Sassolas ; Francoise Borson-Chazot | Diagnostic management of suspected metastatic thyroid carcinoma: clinical value of octreotide scintigraphy in patients with negative high-dose radioiodine scans. |
| 000139 (2002) | Françoise Kraeber-Bodéré (France) ; Catherine Saï-Maurel ; Loïc Campion ; Alain Faivre-Chauvet ; Eric Mirallié ; Michel Chérel ; Stéphane Supiot ; Jacques Barbet ; Jean-François Chatal ; Philippe Thédrez | Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft. |
| 000170 (1999) | N Valli (France) ; B Catargi ; N Ronci ; F Leccia ; M Guyot ; P Roger ; D Ducassou ; A Tabarin | Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy. |
| 000175 (1998) | E Garin (France) ; A Devillers ; J Le Cloirec ; A M Bernard ; J Lescouarc'h ; J Y Herry ; J C Reubi ; P Bourguet | Use of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients without detectable iodine uptake. |
| 000199 (1996) | E Baudin (France) ; M Schlumberger ; J Lumbroso ; J P Travagli ; B Caillou ; C Parmentier | Octreotide scintigraphy in patients with differentiated thyroid carcinoma: contribution for patients with negative radioiodine scan. |
| 000187 (1997) | E Gautherot (France) ; J Bouhou ; J M Le Doussal ; C Manetti ; M Martin ; E Rouvier ; J Barbet | Therapy for colon carcinoma xenografts with bispecific antibody-targeted, iodine-131-labeled bivalent hapten. |
| 000241 (1993) | P Peltier (France) ; C Curtet ; J F Chatal ; J M Le Doussal ; G Daniel ; G Aillet ; A Gruaz-Guyon ; J Barbet ; M Delaage | Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. |
| 000258 (1992) | J P Vuillez (France) ; P Peltier ; J P Caravel ; A Chetanneau ; J C Saccavini ; J F Chatal | Immunoscintigraphy using 111In-labeled F(ab')2 fragments of anticarcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma. |
| 000286 (1989) | L Manil (France) ; F Boudet ; P Motte ; P Gardet ; J C Saccavini ; J D Lumbroso ; M Schlumberger ; B Caillou ; J P Bazin ; M Ricard | Positive anticalcitonin immunoscintigraphy in patients with medullary thyroid carcinoma. |
| 000005 (2013) | C Hennequin (France) ; J-J Mazeron | [Radiobiology in brachytherapy]. |
| 000022 (2012) | Françoise Kraeber-Bodéré (France) ; Pierre-Yves Salaun ; Catherine Ansquer ; Delphine Drui ; Eric Mirallié ; Alain Faivre-Chauvet ; Jacques Barbet ; David M Goldenberg ; Jean-François Chatal | Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC). |
| 000094 (2006) | Françoise Kraeber-Bodéré (France) ; Caroline Rousseau ; Caroline Bodet-Milin ; Ludovic Ferrer ; Alain Faivre-Chauvet ; Loïc Campion ; Jean-Philippe Vuillez ; Anne Devillers ; Chien-Hsing Chang ; David M Goldenberg ; Jean-François Chatal ; Jacques Barbet | Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial. |
| 000095 (2006) | Jean-François Chatal (France) ; Loïc Campion ; Françoise Kraeber-Bodéré ; Stephane Bardet ; Jean-Philippe Vuillez ; Bernard Charbonnel ; Vincent Rohmer ; Chien-Hsing Chang ; Robert M Sharkey ; David M Goldenberg ; Jacques Barbet ; | Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy: a collaborative study with the French Endocrine Tumor Group. |
| 000116 (2005) | Eric Mirallié (France) ; Catherine Saï-Maurel ; Alain Faivre-Chauvet ; Nicolas Regenet ; Chien-Hsing Chang ; David M Goldenberg ; Jean-François Chatal ; Jacques Barbet ; Philippe Thedrez | Improved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibody. |
| 000129 (2003) | Françoise Kraeber-Bodéré (France) ; Alain Faivre-Chauvet ; Ludovic Ferrer ; Jean-Philippe Vuillez ; Pierre-Yves Brard ; Caroline Rousseau ; Isabelle Resche ; Anne Devillers ; Sophie Laffont ; Manuel Bardiès ; Ken Chang ; Robert M Sharkey ; David M Goldenberg ; Jean-François Chatal ; Jacques Barbet | Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial. |
| 000168 (1999) | H Kolesnikov-Gauthier (France) ; D Huglo ; M Nocaudie ; X Marchandise | Factor analysis of dynamic series (FADS) in somatostatin receptor imaging. |
| 000176 (1998) | J Barbet (France) ; P Peltier ; S Bardet ; J P Vuillez ; I Bachelot ; S Denet ; P Olivier ; F Leccia ; B Corcuff ; D Huglo ; C Proye ; E Rouvier ; P Meyer ; J F Chatal | Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody. |
| 000178 (1998) | C Jorgensen (France) ; F Apparailly ; I Couret ; F Canovas ; C Jacquet ; J Sany | Interleukin-4 and interleukin-10 are chondroprotective and decrease mononuclear cell recruitment in human rheumatoid synovium in vivo. |
| 000186 (1997) | C Pérault (France) ; C Schvartz ; H Wampach ; J C Liehn ; M J Delisle | Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne. |
| 000207 (1996) | E Baudin (France) ; J Lumbroso ; M Schlumberger ; J Leclere ; F Giammarile ; P Gardet ; A Roche ; J P Travagli ; C Parmentier | Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma. |
| 000223 (1994) | L Manil (France) ; B Perdereau ; C Barbaroux ; F Brixy | Strong uptake of 111In-pentetreotide by an MIBG-negative, xenografted neuroblastoma. |
| 000249 (1993) | M A Slinkin (France) ; C Curtet ; A Faivre-Chauvet ; C Sai-Maurel ; J F Gestin ; V P Torchilin ; J F Chatal | Biodistribution of anti-CEA F(ab')2 fragments conjugated with chelating polymers: influence of conjugate electron charge on tumor uptake and blood clearance. |
| This area was generated with Dilib version V0.5.76. |  |